Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Canadian Ciprofloxacin Study Group | Zendy

Joseph M. Blondeau | Zendy; Y Yaschuk | Zendy

Open Access

Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Canadian Ciprofloxacin Study Group

Author(s) -

Joseph M. Blondeau,

Y Yaschuk

Publication year - 1996

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.40.7.1729

Subject(s) - ciprofloxacin , microbiology and biotechnology , antimicrobial , haemophilus , moraxella , medicine , biology , antibiotics , bacteria , genetics

We tested 4,507 microorganisms, from 15 Canadian medical centers, against ciprofloxacin and several other antimicrobial agents to determine the in vitro susceptibilities. Overall, susceptibility of members of the family Enterobacteriaceae to ciprofloxacin was 97%; Moraxella and Haemophilus spp. had susceptibilities of 98 and 99%, respectively; and P. aeruginosa and S. aureus had susceptibilities of 79 and 96%, respectively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research